anti-PD-1 antibody - Tikcro Technologies
Keytruda (pembrolizumab) - Merck (MSD)
Libtayo (cemiplimab-rwlc) - Regeneron
http://www.ncbi.nlm.nih.gov/pubmed/39656718
 
Alla Nikolaevski-Berlin; Ido Wolf; Inbar Finkel; Inna Ospovat; Miriam Rivka Brezis; Mor Miodovnik; Orit Gutfeld; Roni Buchen; Yardenna Dolev; Yasmin Leshem
 
Dec 16, 2024
 
Next